Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 |
Microsoft
MSFT
|
$611M |
| 2 |
Shopify
SHOP
|
$441M |
| 3 |
Alibaba
BABA
|
$313M |
| 4 |
NVIDIA
NVDA
|
$189M |
| 5 |
NovoCure
NVCR
|
$171M |
Top Sells
| 1 |
C.H. Robinson
CHRW
|
$389M |
| 2 |
Under Armour
UAA
|
$311M |
| 3 |
Amazon
AMZN
|
$228M |
| 4 |
Meta Platforms (Facebook)
META
|
$199M |
| 5 |
Stellantis
STLA
|
$197M |
Sector Composition
| 1 | Consumer Discretionary | 33.91% |
| 2 | Communication Services | 17.09% |
| 3 | Healthcare | 16.31% |
| 4 | Financials | 10.01% |
| 5 | Technology | 9.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
iRobot
IRBT
$106M
| $87.4M | 0.1% | 742,391 +32,057 | +5% | +$3.77M |
|
102
HEICO Class A
HEI.A
$34.1B
| $85.9M | 0.09% | 1,022,104 +19,458 | +2% | +$1.64M |
|
|
ATVI
103
DELISTED
Activision Blizzard Inc.
ATVI
| $81.5M | 0.09% | 1,789,993 +56,715 | +3% | +$2.58M |
|
104
Sea Limited
SE
$110B
| $80.6M | 0.09% | 3,428,346 -571,258 | -14% | -$13.4M |
|
105
Exact Sciences
EXAS
$8.98B
| $79.2M | 0.09% | 914,779 +30,885 | +3% | +$2.68M |
|
106
Lyft
LYFT
$6.73B
| $78.3M | 0.09% | +1,000,000 | New | +$78.3M |
|
107
Vertex Pharmaceuticals
VRTX
$100B
| $78.2M | 0.09% | 424,845 -302,317 | -42% | -$55.6M |
|
|
RUBY
108
DELISTED
Rubius Therapeutics, Inc
RUBY
| $74.8M | 0.08% | 4,132,851 +76,655 | +2% | +$1.39M |
|
|
PLAN
109
DELISTED
Anaplan, Inc.
PLAN
| $73.7M | 0.08% | 1,871,644 | – | – |
|
110
Pricesmart
PSMT
$3.3B
| $70.6M | 0.08% | 1,198,967 -15,429 | -1% | -$908K |
|
111
Fastenal
FAST
$57B
| $70M | 0.08% | 1,087,893 +39,010 | +4% | +$2.51M |
|
112
Petrobras Class A
PBR.A
$73.9B
| $66.4M | 0.07% | 4,643,130 +239,760 | +5% | +$3.43M |
|
113
Codexis
CDXS
$246M
| $62.8M | 0.07% | 3,057,555 +173,065 | +6% | +$3.55M |
|
|
TERP
114
DELISTED
TerraForm Power, Inc
TERP
| $61M | 0.07% | 4,440,725 +177,905 | +4% | +$2.44M |
|
|
115
C.H. Robinson
CHRW
$15.2B
| $60.7M | 0.07% | 697,517 -4,469,742 | -87% | -$389M |
|
116
STAAR Surgical
STAA
$1.36B
| $60.7M | 0.07% | 1,774,201 +68,680 | +4% | +$2.35M |
|
117
Agios Pharmaceuticals
AGIO
$2.19B
| $58.8M | 0.06% | 872,225 +9,510 | +1% | +$641K |
|
118
AeroVironment
AVAV
$12.1B
| $53.8M | 0.06% | 786,429 +27,491 | +4% | +$1.88M |
|
119
Pinduoduo
PDD
$171B
| $52.7M | 0.06% | 2,126,197 -1,275,037 | -37% | -$31.6M |
|
120
Moderna
MRNA
$9.37B
| $52.4M | 0.06% | 2,575,201 +849,357 | +49% | +$17.3M |
|
121
Teladoc Health
TDOC
$1.37B
| $49.3M | 0.05% | 887,368 +147,326 | +20% | +$8.19M |
|
122
Procter & Gamble
PG
$368B
| $48.4M | 0.05% | 464,909 +51,870 | +13% | +$5.4M |
|
|
BZUN
123
Baozun
BZUN
$196M
| $47M | 0.05% | 1,130,470 +141,559 | +14% | +$5.88M |
|
124
Coca-Cola
KO
$297B
| $46.9M | 0.05% | 1,000,065 +71,696 | +8% | +$3.36M |
|
125
Trupanion
TRUP
$1.99B
| $43.6M | 0.05% | 1,332,260 +39,219 | +3% | +$1.28M |
|